Literature DB >> 20870802

Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival.

Hongxia Li1, Shi Zuo, Zhisong He, Yueting Yang, Zeeshan Pasha, Yigang Wang, Meifeng Xu.   

Abstract

Transplanted mesenchymal stem cells (MSC) release soluble factors that contribute to cardiac repair and vascular regeneration. We hypothesized that overexpression of GATA-4 enhances the MSC secretome, thereby increasing cell survival and promoting postinfarction cardiac angiogenesis. MSCs harvested from male rat bone marrow were transduced with GATA-4 (MSC(GATA-4)) using the murine stem cell virus retroviral expression system; control cells were either nontransduced (MSC(bas)) or transduced with empty vector (MSC(Null)). Compared with these control cells, MSC(GATA-4) were shown by immunofluorescence, real-time PCR, and Western blotting to have higher expression of GATA-4. An increased expression of angiogenic factors in MSC(GATA-4) and higher MSC resistance against hypoxia were observed. Human umbilical vein endothelial cells (HUVEC) treated with MSC(GATA-4) conditioned medium exhibited increased formation of capillary-like structures and promoted migration, compared with HUVECs treated with MSC(Null) conditioned medium. MSC(GATA-4) were injected into the peri-infarct region in an acute myocardial infarction model in Sprague-Dawley rats developed by ligation of the left anterior descending coronary artery. Survival of MSC(GATA-4), determined by Sry expression, was increased at 4 days postengraftment. MSC(GATA-4)-treated animals showed significantly improved cardiac function as assessed by echocardiography. Furthermore, fluorescent microsphere and histological studies revealed increased blood flow and blood vessel density and reduced infarction size in MSC(GATA-4)-treated animals. We conclude that GATA-4 overexpression in MSCs increased both MSC survival and angiogenic potential in ischemic myocardium and may therefore represent a novel and efficient therapeutic approach for postinfarct remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870802      PMCID: PMC3006287          DOI: 10.1152/ajpheart.00557.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  39 in total

1.  Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells.

Authors:  Kazumi Kitta; Regina M Day; Yuri Kim; Ingrid Torregroza; Todd Evans; Yuichiro J Suzuki
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

2.  Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle.

Authors:  Gen Suzuki; Te-Chung Lee; James A Fallavollita; John M Canty
Journal:  Circ Res       Date:  2005-03-10       Impact factor: 17.367

3.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

Authors:  D W Losordo; P R Vale; J F Symes; C H Dunnington; D D Esakof; M Maysky; A B Ashare; K Lathi; J M Isner
Journal:  Circulation       Date:  1998 Dec 22-29       Impact factor: 29.690

4.  Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.

Authors:  Yao Liang Tang; Qiang Zhao; Xinyu Qin; Leping Shen; Leilei Cheng; Junbo Ge; M Ian Phillips
Journal:  Ann Thorac Surg       Date:  2005-07       Impact factor: 4.330

5.  Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4.

Authors:  Jun Wang; Pierre Paradis; Anne Aries; Hiba Komati; Chantal Lefebvre; Hao Wang; Mona Nemer
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes.

Authors:  Meifeng Xu; Maqsood Wani; Yan-Shan Dai; Jiang Wang; Mei Yan; Ahmar Ayub; Muhammad Ashraf
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration.

Authors:  Theo Kofidis; Jorg L de Bruin; Toshiyuki Yamane; Leora B Balsam; Darren R Lebl; Rutger-Jan Swijnenburg; Masashi Tanaka; Irving L Weissman; Robert C Robbins
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

8.  GATA-4 regulation of myocardial survival in the preconditioned heart.

Authors:  Yuichiro J Suzuki; Hiroko Nagase; Regina M Day; Dipak K Das
Journal:  J Mol Cell Cardiol       Date:  2004-12       Impact factor: 5.000

9.  Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity.

Authors:  Anne Aries; Pierre Paradis; Chantal Lefebvre; Robert J Schwartz; Mona Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

10.  Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis.

Authors:  Yuri Kim; Ai-Guo Ma; Kazumi Kitta; Sarah N Fitch; Takayuki Ikeda; Yoshiharu Ihara; Amy R Simon; Todd Evans; Yuichiro J Suzuki
Journal:  Mol Pharmacol       Date:  2003-02       Impact factor: 4.436

View more
  65 in total

1.  Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification.

Authors:  Uta Helmrich; Anna Marsano; Ludovic Melly; Thomas Wolff; Liliane Christ; Michael Heberer; Arnaud Scherberich; Ivan Martin; Andrea Banfi
Journal:  Tissue Eng Part C Methods       Date:  2011-12-19       Impact factor: 3.056

Review 2.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 3.  Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Authors:  Luqia Hou; Joseph J Kim; Y Joseph Woo; Ngan F Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-18       Impact factor: 4.733

4.  Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.

Authors:  Anna Grochot-Przeczek; Jerzy Kotlinowski; Magdalena Kozakowska; Katarzyna Starowicz; Jolanta Jagodzinska; Anna Stachurska; Oscar L Volger; Karolina Bukowska-Strakova; Urszula Florczyk; Magdalena Tertil; Agnieszka Jazwa; Krzysztof Szade; Jacek Stepniewski; Agnieszka Loboda; Anton J G Horrevoets; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

Review 5.  Emergence of the Stem Cell Secretome in Regenerative Engineering.

Authors:  Leila Daneshmandi; Shiv Shah; Tahereh Jafari; Maumita Bhattacharjee; Deandra Momah; Nikoo Saveh-Shemshaki; Kevin W-H Lo; Cato T Laurencin
Journal:  Trends Biotechnol       Date:  2020-07-01       Impact factor: 19.536

Review 6.  Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.

Authors:  Andrey A Karpov; Daria V Udalova; Michael G Pliss; Michael M Galagudza
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

Review 7.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

8.  Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy.

Authors:  Sharven Taghavi; Thomas E Sharp; Jason M Duran; Catherine A Makarewich; Remus M Berretta; Tim Starosta; Hajime Kubo; Mary Barbe; Steven R Houser
Journal:  Clin Transl Sci       Date:  2015-02-11       Impact factor: 4.689

Review 9.  Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.

Authors:  Jinglian Yan; Guodong Tie; Ting Yu Xu; Katharine Cecchini; Louis M Messina
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

10.  Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.

Authors:  Sarah T Hsiao; Zerina Lokmic; Hitesh Peshavariya; Keren M Abberton; Gregory J Dusting; Shiang Y Lim; Rodney J Dilley
Journal:  Stem Cells Dev       Date:  2013-03-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.